Mobile

A multi-center, randomized, double-blinded, placebo-controlled, multiple dose study to assess the efficacy of intravenously administered RSV604 in immunocompromised adults with evidence of RSV infecti...

Update Il y a 4 ans
Reference: EUCTR2006-006410-15

A multi-center, randomized, double-blinded, placebo-controlled, multiple dose study to assess the efficacy of intravenously administered RSV604 in immunocompromised adults with evidence of RSV infection

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine the ability of RSV604 to significantly reduce nasopharyngeal viral load during 5 days of intravenous therapy compared with placebo in immunocompromised adult patients with evidence of RSV infection. To determine the safety and tolerability of RSV604 when administered intravenously in immunocompromised adult patients with RSV infection.

Inclusion criteria

  • Respiratory Syncytial Virus (RSV) Infection

Links